-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

506.O1.6 506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Hematopoietic Stem Cell Niche

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 2:45 PM-4:15 PM
W304EFGH, Level 3 (Orange County Convention Center)
Moderators:
Jonathan Hoggatt, PhD, Massachusetts General Hospital and Louis M. Pelus, PhD, Indiana University School of Medicine

Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Noboru Asada, MD, PhD1*, Yuya Kunisaki, MD, PhD2*, Takashi Nagasawa, MD, PhD3* and Paul S. Frenette, MD2

1Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY
2Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY
3Department of Immunobiology and Hematology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan

3:00 PM

Andres Garcia-Garcia, BSc1,2* and Simon Mendez-Ferrer, PhD2,3

1Stem Cell Niche Pathophysiology Group. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
2Stem Cell Institute and Department of Haematology, University of Cambridge, and National Health Service Blood and Transplant, Cambridge, United Kingdom
3Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

3:15 PM

Lev Silberstein, MD PhD1,2, Peter V. Kharchenko, Ph.D.3*, Youmna Sami Kfoury, PhD,1*, Francois Mercier, MD, FRCPC4, Raphael Turcotte, PhD5*, Charles P. Lin2*, Ninib Baryawno, PhD1*, Nicolas Severe1,2*, Tiffany Tate, BS6*, Jonathan Hoggatt, PhD1,2 and David T. Scadden, MD6,7

1Harvard Stem Cell Institute, Cambridge
2Massachusetts General Hospital, Boston
3Department of Biomedical Informatics, Harvard Medical School, Boston, MA
4Harvard Stem Cell Institute, Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
5Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
6Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
7Harvard Stem Cell Institute, Cambridge, MA

3:30 PM

Tomer Itkin, PhD1*, Shiri Gur Cohen, PhD1*, Joel A. Spencer, PhD2*, Amir Schajnovitz3*, Saravana K. Ramasamy, PhD4*, Anjali P. Kusumbe, PhD4*, Yookyung Jung, PhD5*, Guy Ledergor, MD1*, Idan Milo, PhD1*, Michael Gustave Poulos, PhD6*, Maria Garcia Fernandez, PhD7*, Alexander Kalinkovich, MD PhD1*, Aya Ludin1*, Orit Kollet, Ph.D1, Guy Shakhar, PhD8*, Simon Mendez-Ferrer, PhD9,10, Jason M. Butler, PhD11, Shahin Rafii, MD12, Ralf H. Adams, PhD4*, David T. Scadden, MD3,13,14, Charles P. Lin5* and Tsvee Lapidot, PhD1

1Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
2Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
4Max Planck Institute for Molecular Biomedicine, Munster, Germany
5Massachusetts General Hospital, Boston
6Ansary Stem Cell Institute/Genetic Medicine, Weill Cornell Medical College, New York, NY
7Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain
8The Weizmann Institute of Science, Rehovot, Israel
9Stem Cell Institute and Department of Haematology, University of Cambridge, and National Health Service Blood and Transplant, Cambridge, United Kingdom
10Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
11Ansary Stem Cell Institute, Weill Cornell Medical College, New York, NY
12Department of Medicine, Weill Cornell Medical College, New York, NY
13Harvard Stem Cell Institute, Cambridge, MA
14Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA

3:45 PM

Sachin Kumar, PhD1*, Jeff Vassallo, PhD1*, Kalpana Nattamai, MSc1*, Jose A Cancelas, MD, PhD1 and Hartmut Geiger, PhD2,3

1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, cincinnati, OH
2Institute of Molecular Medicine, Ulm University, Ulm, Germany
3Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

4:00 PM

Grazia Abou Ezzi, PhD1*, Teerawit Suparkorndej2*, Bryan Anthony2*, Jingzhu Zhang, BS3, Shilpi Ganguly4*, Roberto Civitelli5* and Daniel C. Link2

1Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of medicine, Saint Louis, MO
2Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, Saint Louis, MO
3Department of Internal Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, St Louis, MO
4Washington University School of Medicine, Saint Louis, MO
5Int Med - Bone & Mineral Diseases, Washington University School of Medicine, Saint Louis, MO

*signifies non-member of ASH